Vertanical GmbH
PrivateTotal Funding Raised
$300M
Company Overview
Vertanical GmbH is a biopharmaceutical company that develops and distributes innovative cannabinoid-based therapies for the treatment of chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vertanical GmbH Comparables
Compare Vertanical GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DEMECAN | 76% | |
| Bod Science | 71% | |
| Grünenthal Group | 69% | |
Vertanical GmbH Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 14, 2026
Grew 15% QoQ, from 66 to 76 employees.
- May 1, 2025
Grew 23% QoQ, from 57 to 70 employees.
Vertanical GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vertanical GmbH's valuation, stock price, and market status.